BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Nexstim: Issuance of Shares Pursuant to the Restricted Share Unit Reward Plan

  The Company has today resolved on issuing altogether 9,910 new shares without payment to two members of the Board of Directors.

  December 14, 2017

   · 

  2 min read
• 

  Deals

  argenx Bags $231M in Upsized U.S. IPO

  argenx increased the Offering from the initially filed offering size of $150 million.

  December 14, 2017

   · 

  6 min read
• Business

  France Biotech Grants Best 2017 Health Entrepreneur Awards

  France Biotech, the leading organization representing French health innovation entrepreneurs, just announced the winners of this year’s Health Entrepreneur Awards, following the release of its “2017 French Health Tech Survey.”"

  December 14, 2017

   · 

  4 min read
• Genetown

  Proteostasis Therapeutics Prices Public Offering of Common Stock

  The gross proceeds to Proteostasis from the offering, before underwriting discounts and commissions and offering costs, are expected to be $40 million

  December 14, 2017

   · 

  4 min read
• Business

  Telix Pharmaceuticals and Memorial Sloan Kettering Cancer Center Announce Renal Cancer Collaboration

  The clinical objective is to use imaging as a precision medicine tool to rapidly determine an optimal therapeutic strategy for the patient.

  December 14, 2017

   · 

  4 min read
• MorphoSys to Present at Upcoming Investor Conferences

  MorphoSys will present at the following conferences.

  December 14, 2017

   · 

  3 min read
• Genetown

  Dicerna Announces Pricing of Follow-On Public Offering of 5,714,286 Shares of Common Stock

  Dicerna announced today the pricing of its underwritten registered public offering of 5,714,286 shares of its common stock at a price to the public of $7.00 per share.

  December 14, 2017

   · 

  5 min read
• Drug Development

  BeyondSpring Meets Primary Objective in Phase II Portion of Phase II/III Trial (Study 105) with Plinabulin for the Prevention of Docetaxel Chemotherapy-Induced Neutropenia (CIN)

  Initial data from the Phase 2 portion of Study 105 will be presented at the 2018 ASCO-SITC Clinical Immuno-Oncology Symposium in San Francisco on Jan. 25-27, 2018.

  December 14, 2017

   · 

  7 min read
• BioCapital

  India Globalization Capital Provides Update on Hyalolex for Alzheimer’s Commercialization Strategy

  Here’s an update on corporate initiatives to launch its lead product for Alzheimer’s.

  December 14, 2017

   · 

  2 min read
• Genetown

  owancMicrobot Receives Notice of Alle for U.S. Patent Covering Its TipCAT Technology Platform

  This increases the number of issued or allowed patents to 24 and an additional 12 patent applications pending worldwide, covering its ViRob™ and TipCAT™ technology platforms.

  December 14, 2017

   · 

  4 min read